|
CN1255057A
|
|
Aqueous pharmaceutical composition comprising active ingredient which is highly insoluble in water
|
|
AU6395398A
|
|
A composition for administration by the intranasal, sublingual or vaginal route
|
|
AU5552698A
|
|
Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds and their use as cyclooxygenase i (cox i) inhibitors
|
|
ITMI970867A1
|
|
Indazolamides as serotonergic agents
|
|
ITMI970362A1
|
|
PHARMACEUTICAL PREPARATION INCLUDING LYOPHYLIZED LIPOSOMES IN WHICH A HIGHLY WATER-INSOLUBLE ACTIVE SUBSTANCE IS ENCAPSULATED AND
|
|
IL124291A
|
|
Pharmaceutical composition comprising bindarit and an immunosuppressant for the treatment of autoimmune diseases
|
|
WO9714694A1
|
|
An improved process for producing heptastigmine and a new intermediate compound useful in this process
|
|
SK10596A3
|
|
Use of benzydamine in the treatment of pathological conditions caused by tumor necrosis factor
|
|
AU3350493A
|
|
Alkyl derivatives of trazodone with CNS activity
|
|
HU9201334D0
|
|
Process for producing pharmaceutical compositions suitable for treating autoimmune diseases and comprising benzylindazole derivatives
|
|
EP0510748A1
|
|
Use of a methoxy alkanoic acid of indazole for the manufacture of a medicament for the treatment of autoimmune diseases
|
|
EP0496709A1
|
|
Disposable sanitary towel provided with improved lateral tabs and method of manufacture thereof
|
|
EP0455607A1
|
|
Absorbent element incorporating hydrogel, and article including said element
|
